Brookfield Property Partners 5750 BPYPN Holds Steady Near Key Resistance Level Innoviz Technologies INVZ Slides Toward Support Amid Continued Selling Pressure Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29 Lixte Biotechnology Holdings LIXT Faces Selling Pressure as Shares Dip 34